Hero image 0 of Crayola BAS345 Portfolio Series Acrylic Paint - Brilliant Blue Purple, 0 of 7

Crayola BAS345 Portfolio Series Acrylic Paint - Brilliant Blue Purple

Name: Crayola BAS345 Portfolio Series Acrylic Paint - Brilliant Blue Purple
Brand: Crayola
SKU: 26421194
Price: 24.85 USD
Availability: OutOfStock

(No ratings yet)

Crayola BAS345 Portfolio Series Acrylic Paint - Brilliant Blue Purple Crayola Portfolio Acrylic Paint Brilliant Blue Purple Pint 2 pack Crayola Portfolio Non Toxic Acrylic Paint 1 pt Squeeze Bottle Brilliant Blue Purple

Pack Size:Single-Out of stock

Key item features

Pigment enriched color dries to a flexible water-resistant finish
Clean up wet paint with soap and water
AP certified

Specs

Art paint type
Acrylic
Brand
Crayola
Color
Brilliant Blue Purple
Features
Permanent
Dyes & paints form
Liquid
Size
Pint (16 oz)

Current price is $24.85

Price when purchased online

Out of stock

How do you want your item?

Out of stock

Report an issue with this seller

About this item

Product details

Crayola BAS345 Portfolio Series Acrylic Paint - Brilliant Blue Purple

Pigment enriched color dries to a flexible water-resistant finish
Clean up wet paint with soap and water
AP certified

info:

We aim to show you accurate product information. Manufacturers, suppliers and others provide what you see here, and we have not verified it.

Warranty

Warranty information

Warranty not available for this item

Please be aware that the warranty terms on items offered for sale by third party Marketplace sellers may differ from those displayed in this section (if any). To confirm warranty terms on an item offered for sale by a third party Marketplace seller, please use the 'Contact seller' feature on the third party Marketplace seller's information page and request the item's warranty terms prior to purchase.

Warnings

Warning Text

proposition 65 reasons:titanium dioxide, other chemicals

WARNING: This product may expose you to chemicals including lead, which are known to the state of California to cause cancer and birth defects or other reproductive harm.